Abstract
Introduction

The program of adipogenesis is orchestrated by a sequential activation of transcription factors transducing information from intracellular and extracellular factors indicative of suitable condi-
tions for differentiation [1] [2] [3] . Several factors have been associated with dynamic changes of adipose tissue [4] . Particular attention was recently given to the role of the gastric hormone, ghrelin, on its role in the regulation of adipocyte biology [5] . The net effect of prolonged ghrelin exposure is hyperphagia [6, 7] . At central level, ghrelin promote ubiquitous fat deposition independent of its orexigenic activity [6, 8, 9] . Peripheral ghrelin promotes the enlargement of adipocytes in specific abdominal white adipose tissue (WAT) deposits by enhancing lipid accumulation [10] . This is further supported by augment of adipogenesis [11, 12] , intracellular lipid accumulation [13] , triglyceride content [14] and reduction of lipolysis [10, 14, 15] . # The ghrelin gene encodes a polypeptide called preproghrelin, which undergoes stepwise processing to produce ghrelin [16] . Preproghrelin undergoes additional proteolytic cleavage, generating a 23-amino-acid peptide named obestatin [17] . This peptide was originally isolated from stomach showing to be a circulating peptide whose secretion is pulsatile and displays an ultradian rhythmicity similar to ghrelin and growth hormone secretion [17] . It was originally reported to be the ligand for the orphan receptor GPR39, which belongs to the family of the ghrelin receptor GHSR1a and the motilin receptor [17] . Despite the initial enthusiasm about the potential of this molecule as a physiological opponent of ghrelin, several observations related to this point have set its effectiveness into question [18] [19] [20] [21] . Consequently, the state-ofknowledge on obestatin suffers from serious gaps, especially for the lack of reproducibility of its central activities. Keeping aside its controversial anorexigenic activity, there are data suggesting a relevant biological role, such as the mitogenic effect described in 3T3-L1 pre-adipocyte [21] , human gastric carcinoma [22, 23] and pancreatic ␤ cells [24] . Furthermore, obestatin induced c-fos expression in gastrointestinal and white adipose tissues through binding to GPR39 [21] . Of interest, GPR39 expression in white adipose tissues of rats was up-regulated during fasting whereas GPR39 levels were decreased in cultured mouse embryonic fibroblast cell lines during adipogenesis [25] . In human adipose tissue, decreased GPR39 expression was found in patients with obesity-associated type 2 diabetes mellitus [26] . These findings suggest a possible role for obestatin in adipocyte function. Thus, to shed light on the hypothetical role of obestatin in the biology and pathology of adipose tissue, we determined the effect of obestatin on the control of the metabolism of adipocyte and WAT as well as on adipogenesis focusing on the regulation of key enzymatic nodes for metabolism, Akt and AMPK [27, 28] . 
Methods
Materials
Data analysis
Comparisons between groups were made by ANOVA. P Ͻ 0.05 was considered as statistically significant (*,#,##).
Results
Obestatin activates Akt phosphorylation and AMPK dephosphorylation in 3T3-L1 adipocyte cells
First, the dose dependence of Akt activation by obestatin was examined in 3T3-L1 adipocytes. Akt phosphorylation at C-terminal hydrophobic motif (S473) [HM(S473); pAkt(S473)] was observed using 10 nM obestatin, and the level of pAkt(S473) plateaued at 100-200 nM (data not shown). Next, we examined the kinetic of Akt activation in response to obestatin. Significant pAkt(S473) augment was observed 10 min. after addition of obestatin (100 nM), being sustained by 60 min. (Fig. 1A). Parallel to Akt activation, obestatin (100 nM) triggered the phosphorylation of a broad range of Akt downstream substrates: GSK3␣/␤ (S21/9), AS160(T642), mTOR(S2448) and S6K1(T384) (Fig. 1B and C). Importantly, dephosphorylation of pAMPK␣(T172) and its downstream substrate ACC(S79) was observed in response to obestatin (100 nM) (Fig. 1C).
Obestatin activates Akt phosphorylation and AMPK dephosphorylation in WAT
For in vivo obestatin administration, osmotic minipumps were selected based on the short half-life of this peptide (~22 min.) (Fig. 1D) . pAMPK␣(T172) was decreased by 20% to basal phosphorylation in omental WAT with no effect in subcutaneous and gonadal WAT (Fig. 1D) (Fig. 2C) .
Fig. 1 Obestatin activates Akt phosphorylation and AMPK dephosphorylation in 3T3-L1 adipocyte cells and WAT. Time-course of the effect of obestatin (100 nM) on: (A) pAkt(S473) and pAMPK␣(T172); (B) pGSK3␣/␤(S21/9) and pAS160(T642) and (C) pmTOR(S2448), pS6K1(T384) and pACC(S79). Phosphorylation was expressed as a percentage of the maximal phosphorylation obtained for each residue (n ϭ 3; meanϮS.E.). Blots are representative of three independent experiments. (D) Effect of 24 hrs continuous sc infusion of obestatin (300 nmol/kg body weight/24 hrs; n ϭ 10) on pAkt(S473) and pAMPK␣(T172) from subcutaneous, gonadal and omental WAT obtained from male rats. (E) Effect of 72 hrs continuous sc infusion of obestatin
Obestatin shows no effect on FATP1, FATP4 and FAT/CD36 translocation to plasma membrane in 3T3-L1 adipocyte cells
The levels of fatty acid (long chain) transport proteins 1 and 4 (FATP1 and FATP4) and fatty acid translocase (FAT/CD36) at the plasma membrane were examined by subcellular fractionation. As shown in Fig. 2D, obestatin (100 nM, 30 30 min.; Fig. 2D ). (Fig. 3A) . The effect of acute GPR39 deficiency was determined by means of siRNA in 3T3-L1 pre-adipocyte cells. Under these conditions, the constructs decreased GPR39 expression by 50Ϯ10% (Fig. 3B) (Fig. 3C) . Fig. 3D ) induced more lipid droplets (~1.6-fold) than insulin treatment (Group 1, Fig. 3D ). The accumulation was higher in cells maintained in DMEM/10% FBS with obestatin (392 nM) for 7 days after induction of differentiation (Group 3, Fig. 3D ), but fewer than that observed in full dose insulin-treated cells (172 nM) for 7 days (Group 4, Fig. 3D (Fig. 4A) . Furthermore, C/EBP␦ protein expression peaked around 6 hrs after obestatin treatment (Fig. 4B) .
Obestatin promotes adipogenesis in vitro
). Supporting this scenario, in obestatin-treated 3T3-L1 differentiating adipocytes, C/EBP␤ protein expression markedly increased at 24 hrs for p32 and p35 isoforms, respectively
Fig. 2 (A) Western blot analysis of GLUT4 and GLUT1 expression in membrane from 3T3-L1 adipocyte cells treated with obestatin (100 nM) or insulin (172 nM) for 30 min. GLUT expression was expressed as a percentage of basal expression obtained in control cells (n ϭ 3; meanϮS.E.). (B) Immunofluorescence analysis of obestatin-induced GLUT4 translocation in 3T3-L1 adipocyte cells. Serum-starved cells were stimulated with obestatin (100 nM, 30 min.) and the amount of GLUT4 was determined by labelling with anti-GLUT4 antibody in combination with Alexa 594-conjugate goat antirabbit antibody in permeabilized cells. (C) Obestatin dose dependently stimulated 2-[ 3 H]deoxyglucose uptake in 3T3-L1 adipocyte cells (n ϭ 3; meanϮS.E.). Non-specific uptake was measured in the presence of 20 M cytochalasin B (cyB). (D) Western blot analysis of FATP1, FATP4 and FAT/CD36 expression in membrane from 3T3-L1 adipocyte cells treated with 100 nM obestatin or with 172 nM insulin for 30 min. FATP1, FATP4 and FAT/CD36 expression were expressed as a percentage of basal expression obtained in control cells (n ϭ 3; meanϮS.E.). For (A, D) expression of GHSR1a was determined to ensure equal membrane protein loading. Blots are representative of three independent experiments. Asterisk ( * ) denotes P Ͻ 0.05 when comparing obestatin-treated group with untreated control group.
Fig. 3 (A) Time-course of the effect of obestatin (100 nM) on pAkt(S473) and pAMPK␣(T172) in 3T3-L1 pre-adipocyte cells. Phosphorylation was expressed as a percentage of the maximal phosphorylation obtained for each residue (n ϭ 3; meanϮS.E.). (B) Effect of siRNA depletion of GPR39 on obestatin-activated pAkt(S473) (100 nM, 5 min.) in 3T3-L1 pre-adipocyte cells. Expression of pAkt(S473) and GPR39 was expressed as fold of their levels in control siRNA-transfected cells (n ϭ 3; meanϮS.E.). (C) 3T3-L1 cells display an obestatin-dependent increase in adipogenesis. 3T3-L1 pre-adipocyte cells were maintained in DMEM containing 10% FBS with different concentrations of obestatin, ghrelin or insulin (172 nM) for 7 days after induction of differentiation by combination of 0.5 mM IBMX/25 M DEX/861 nM insulin for 3 days. Lipid droplet accumulation was analysed by spectrophotometry at 520 nm by Oil red O staining. Results are expressed as a fold of lipid accumulation over differentiation control (cells maintained in DMEM/10% FBS/172 nM insulin for 7 days after induction of differentiation under treatment with 0.5 mM IBMX/25 M DEX/861 nM insulin for 3 days; n ϭ 3; meanϮS.E.). Representative microscope fields of view (right) are shown at the same magnification. (D) Effect of obestatin as initiatr of adipogenesis. 3T3-L1 pre-adipocyte cells were maintained in DMEM containing 10% FBS with obestatin (392 nM) or insulin (172 nM) for 7 days after induction of differentiation by treatment with 0.5 mM IBMX, 25 M DEX, 861 nM insulin or 1.96 M obestatin for 3 days. Lipid droplet accumulation was analysed by spectrophotometry at 520 nm by Oil red O staining. Results are expressed as fold of lipid accumulation over differentiation control (cells maintained in DMEM/10% FBS/172 nM insulin for 7 days after induction of differentiation by treatment with 0.5 mM IBMX/25 M DEX/861 nM insulin for 3 days; n ϭ 3; meanϮS.E.
Consistently, obestatin treatment strongly increased the expression of PPAR␥ proteins peaking at 48 and 144 hrs of differentiation for PPAR␥1 and PPAR␥2 isoforms, respectively (Fig. 4C). In addition, this treatment also increased the expression of C/EBP␣ proteins peaking at 24 and 72 hrs for p30 and p42 isoforms, respectively (Fig. 4D).
Preproghrelin expression increases throughout adipogenesis
We first examine obestatin expression in 3T3-L1 pre-adipocyte and adipocyte cells at protein level, utilizing immunocytochemistry.
3T3-L1 adipocyte cells showed a stronger obestatin expression (Fig. 5B) compared to that observed in 3T3-L1 pre-adipocyte cells (Fig. 5A). No immunostaining was found with obestatin antibody pre-adsorption control in 3T3-L1 adipocyte cells (Fig. 5C). This result leads us to focus on preproghrelin expression along adipogenesis as source of obestatin. Preproghrelin expression was examined at mRNA and protein level, by RT-PCR and immunoblot, respectively, in 3T3-L1 pre-adipocyte cells. The cells were maintained in DMEM containing 10% FBS with insulin (172 nM) for 7 days after induction for 3 days (0.5 mM IBMX, 25 M DEX and 861 nM insulin). The amount of preproghrelin mRNA showed a biphasic pattern of expression. A rapid augment was observed at 6 hrs (~1.7-fold; Fig. 5D), to reach values bellow basal by 24 hrs after the induction of differentiation. Preproghrelin mRNA expression increased from 48 hrs, becoming maximal 72 hrs after induction to be sustained throughout terminal differentiation. As Fig. 5E shows, there is a rapid augment of preproghrelin protein expression at the time of differentiation into adipocytes (~4.0-fold, 6 hrs after induction) reaching a maximum 24 hrs after induction of differentiation (~5.8-fold) concomitant with the minimum of preproghrelin mRNA expression (Fig. 5D). Intriguingly, preproghrelin protein expression decreased 48 hrs after induction of differentiation to be sustained along terminal differentiation being higher than that in pre-adipocyte cells (~2.4-fold at 240 hrs). Furthermore, GPR39 protein expression decreased in terminal differentiation compared to undifferentiated 3T3-L1 cells (~40% reduction,
Fig. 4 Immunoblots showing the expression pattern of: (A) C/EBP␤, (B) C/EBP␦ , (C) PPAR␥ and (D) C/EBP␣. 3T3-L1 pre-adipocyte cells were maintained in DMEM containing 10% FBS, obestatin (392 nM) or insulin (172 nM) for 7 days after induction of differentiation by treatment with 0.5 mM IBMX, 25 M DEX, 10% FBS, 861 nM insulin or 1.96 M obestatin for 3 days [in (D), asterisk (*) denotes unspecific band]. Data were expressed as percentage of control expression (n ϭ 3; meanϮS.E.). Blots are representative of three independent experiments.
240 hrs after induction; Fig. 5F ), showing two maximal expression levels concomitant with the maximum of preproghrelin expression (Fig. 5D) . (Fig 5G-I, respectively) .
Consistent with the results from cultured cells, immunohistochemical analysis confirmed the expression of obestatin in subcutaneous, gonadal and omental WAT obtained from male ad libitum rats
Autocrine/paracrine role of obestatin on adipogenesis
The [27, [30] [31] [32] [33] [34] . One of the physiological functions of Akt is to stimulate glucose uptake by GLUT4 trafficking through the Rab GAP (GTPase-acting protein) known as AS160 [35] [36] [37] [38] . It was described five putative Akt phosphorylating sites on AS160 of which T642 appears to be critical for mediating the GLUT4 translocation and glucose uptake in response to insulin [36] [27] . In this sense, obestatin inactivated GSK3␣/␤, an Akt substrate, through phosphorylation in 3T3-L1 adipocyte cells. This inactivation leads to a decrease in the phosphorylation of glycogen synthase (GS) resulting in its activation, thereby stimulating glycogen synthesis [40] . Apart from GS, translation initiation factor 2B (eIF2B) can be also activated in a similar way leading to an increase in the glycogen synthesis and the protein synthesis [40] . Furthermore, inactivation of GSK3 has been shown to avoid degradation of the sterol regulatory element-binding proteins (SREBPs), which are transcription factors that trigger the expression of genes involved in cholesterol and fatty acid biosynthesis [41] . Consequently, Akt-directed signaling coordinates the obestatin-evoked glucose uptake and storage as glycogen in adipose tissue by regulation of AS160 and GSK3. In addition to glucose uptake, obestatin showed to regulate mTORC1/S6K1 signaling, a critical element integrating cellular metabolism with growth factor signaling [42] . mTORC1 controls many aspects of cellular metabolism including fat metabolism [42] [43] [44] . In particular, mTORC1/S6K1 plays an important role in adipogenesis and, thus, in lipid accumulation [43] . Loss of mTORC1/S6K1 activity correlates with a decrease in fat accumulation, suggesting that the mTOR pathway is required for fat accumulation [45, 46] . Furthermore, activation of mTORC1 signaling is a critical step in adipocyte differentiation [46] . [24] and gastric cell lines [23] . In gastric cell lines, a signaling pathway involving a ␤-arrestin 1 scaffolding complex and EGFR to activate Akt signaling is proposed [23] . It [48] . We can hypothesize that ghrelin and obestatin mutually contribute to adipogenesis as pro-adipogenic factors promoting lipogenesis. Indeed, it has been shown that ghrelin stimulates lipid accumulation in vitro [13, 49] and in vivo [5, 10] 
Fig. 5 Immunocytochemical detection of obestatin in 3T3-L1 pre-adipocyte (A) and adipocyte cells (B) (objective magnification 40ϫ). Obestatin immunostaining was mainly localized in the cytoplasm of 3T3-L1 adipocytes while it was faint in 3T3-L1pre-adipocyte cells. (C) Pre-adsorption control with mouse obestatin (10 nmol/ml) showed no positive immunostaining. (D) Preproghrelin mRNA levels in the course of adipogenesis. (E, F) Western blot analysis of preproghrelin (E) and GPR39 (F) expression in the course of adipogenesis. Preproghrelin expression at mRNA or protein levels, were examined in 3T3-L1 pre-adipocyte cells maintained in DMEM containing 10% FBS with insulin (172 nM) for 7 days after induction for 3 days (0.5 mM IBMX, 25 M DEX and 861 nM insulin). Protein expression was expressed as a fold over control cells (n ϭ 3; meanϮS.E.). mRNA was quantified by RT-PCR and expressed as arbitrary units (n ϭ 5; meanϮS.E.). (G-I) Immunohistochemical detection of obestatin in subcutaneous (G), gonadal (H) and omental (I) WAT (objective magnification 20ϫ
